Zur Fortbildung empfohlene Übersichtsarbeiten

2018

  • PCSK9 inhibition for LDL lowering and beyond – implications for patients with peripheral artery disease
    Karin Gebauer and Holger Reinecke (Vasa 3/2018)

  • Do not underestimate the femoral pseudoaneurysm
    Maria Stolt, Ruediger Braun-Dullaeus, and Joerg Herold (Vasa 3/2018)

  • Mortality after endovascular treatment of infrarenal abdominal aortic aneurysms – the newer the better?
    Aspasia Tzani, Ilias P. Doulamis, Ioannis Katsaros, Eirini Martinou, Dimitrios Schizas, and Konstantinos P. Economopoulos (Vasa 3/2018)

  • Management of cancer-associated venous thromboembolism – a case-based practical approach
    Minna Voigtlaender and Florian Langer (Vasa 2/2018)

  • Erythromelalgia
    Peter Franz Klein-Weigel, Theresa Sophie Volz, and Jutta Gisela Richter (Vasa 2/2018)

  • Antithrombotic treatment in peripheral artery disease
    Dan-Mircea Olinic, Dan Alexandru Tataru, Calin Homorodean, Mihail Spinu, and Maria Olinic (Vasa 2/2018)

  • Carotid stenosis – basing treatment on individual patients’ needs. Optimalmedical therapy alone or accompanied by stenting or endarterectomy Ralf Langhoff (Vasa 1/2018)

  • Surgical and endovascular venous arterialization for treatment of critical limb ischaemia
    Michael Lichtenberg, Michiel A. Schreve, Roberto Ferraresi, Daniel A. F. van den Heuvel, Çagdas Ünlü, Vincent Cabane, and Steven Kum (Vasa 1/2018)
  • Posterior nutcracker syndrome – a systematic review
  • Jae Hyon Park, Gi Hoon Lee, Seul Mi Lee, Michael Eisenhut, Andreas Kronbichler, Keum Hwa Lee, and Jae Il Shin (Vasa 1/2018)

    2017

    • ESVM guidelines – the diagnosis and management of Raynaud’s phenomenon
      Jill Belch, Anita Carlizza, Patrick H. Carpentier, Joel Constans, Faisel Khan, Jean-Claude Wautrecht, Adriana Visona, Christian Heiss, Marianne Brodeman, Zsolt Pécsvárady, Karel Roztocil, Mary-Paula Colgan, Dragan Vasic, Anders Gottsäter, Beatrice Amann-Vesti, Ali Chraim, Pavel Poredoš, Dan-Mircea Olinic, Juraj Madaric, Sigrid Nikol, Ariane L. Herrick, Muriel Sprynger, Peter Klein-Weigel, Franz Hafner, Daniel Staub, and Zan Zeman (VASA 6/2017)  
    •  Primary aorto-enteric fi stula as a rare cause of massive gastrointestinal haemorrhage 
      Christian-Alexander Behrendt, Sabine Wipper, Sebastian E. Debus, Yskert von Kodolitsch, Klaus Püschel, Michael Kammal, and Anna Kammal (VASA 6/2017)  
    • History of vascular reactivity models and their involvement in hypertension pathogenesis
      Ana Gabriela Conceição-Vertamatti, Filipy Borghi, Fernando Canova and Dora Maria Grassi-Kassisse (VASA 6/2017)  
    • Clinical and duplex ultrasound evaluation of lower extremities varicose veins - a practical guideline
      Luca Spinedi, Pavel Broz, Rolf Peter Engelberger, Daniel Staub, Heiko Uthoff (VASA 5/17) 
    • Statement for Doppler waveforms analysis
      Guillaume Mahé, Carine Boulon, Ileana Desormais, Philippe Lacroix, Luc Bressollette, Jean-Louis Guilmot, Claire Le Hello, Marie-Antoinette Sevestre, Gilles Pernod, Joel Constans, Christian Boissier, Alessandra Bura-Rivière (VASA 5/2017)
    • Erectile dysfunction - overview from a cardiovascular perspective
      Frederic Baumann, Deborah Hehli, Vladimir Makaloski, Martin Schumacher, Heinz Schönhofen, Nicolas Diehm (VASA 5/2017)
    • Ultrasound imaging in the diagnosis of large vessel vasculitis
      Michael Czihal, Christian Lottspeich, and Ulrich Hoffmann (VASA 4/17) 
    • Clinical and diagnostic aspects of lymphedema
      Hong H. Keo, Silvia B. Gretener, and Daniel Staub (VASA 4/17) 
    • Associations of coronary and peripheral artery disease with presence, expansion, and rupture of abdominal aortic aneurysm – a grin without a cat!
      Hisato Takagi and Takuya Umemoto (VASA 3/17) 
    • Endovenous ablation of refl uxing saphenous and perforating veins 
      Thomas Proebstle and Renate van den Bos (VASA 3/17)
    • Credentialing in interventional therapy in Europe – comparison of curricula including endovascular therapy of arterial diseases
      Karl-Ludwig Schulte, Pia M. Jungmann, Vladimir Makaloski, Lino Goncalves, Markus Steinbauer, Susanne Vonberg, Beatrix B. Doerr, Ralf Langhoff, and Frederic Baumann (VASA 3/17)
    • German guideline on the diagnosis and treatment of peripheral artery disease – a comprehensive update 2016
    • Holger Lawall, Peter Huppert, Christine Espinola-Klein, Claudia Silke Zemmrich, and Gerhard Ruemenapf (VASA 2/17)
    • The optimal duration of anticoagulant therapy after unprovoked venous thromboembolism – still a challenging issue
      Giovanna Elmi, Giuseppe Di Pasquale and Raffaele Pesavento (VASA 2/17)
    • Varicose vein therapy and nerve lesions
      Tobias Hirsch (VASA 2/17)
    • Endovascular management of infected iliofemoral pseudoaneurysms – a systematic review
      Konstantinos G. Moulakakis, Vangelis G. Alexiou, George S. Sfyroeras, John Kakisis, Andreas Lazaris, Spyridon N. Vasdekis, Elias N. Brountzos, George Geroulakos (VASA 1/17)
    • Registry and health insurance claims data in vascular research and quality improvement
      Christian-Alexander Behrendt, Franziska Heidemann, Henrik Christian Rieß, Konstanze Stoberock, Sebastian Eike Debus (VASA 1/17)

     

     

    2016

    Effects of perinatal, late fetal, and early embryonic insults on the cardiovascular phenotype in experimental animal models and humans
    Theo Arthur Meister, Emrush Rexhaj, Stefano Flavio Rimaldi, Urs Scherrer, Claudio Sartori (VASA 6/16)

    Clinical relevance of cerebral blood pressure - a critical review
    Michael Kostapanos, Carmel M. McEniery, Ian B. Wilkinson (VASA 6/16)

    Vascular puncture site complications - diagnosis, therapy and prognosis
    Wolfgang Mlekusch, Irene Mlekusch, Schila Sabeti-Sandor (VASA 6/16)

    Nailfold capillaroscopy microscopy – an interdisciplinary appraisal
    Peter Frank Klein-Weigel, Cord Sunderkötter, Oliver Sander (VASA 5/16)

    Angioplasty wioth drug coated balloons for the treatment of infrainguinal peripheral artery disease
    Martin Werner (VASA 5/16)

    Endovascular treatment of ischaemic stroke patients – new evidence and old challenges 
    Johannes Gerber, Volker Puetz, Ulf Bodechtel, Hagen Kitzler, Ruediger von Kummer, Jennifer Linn (VASA 4/16)

    Pelvic congestion syndrome and left renal compression syndrome – clinical features and therapeutic approaches 
    Christina Jeanneret, Konstantin Beier Alexander von Weymarn, Jürg Traber (VASA 4/16)

    Management of lymphedema
    Ahmet Yüksel, Orçun Gürbüz, Yusuf Velioğlu, Gencehan Kumtepe, Sefa Şenol (VASA 4/16)

    Chronic thromboembolic pulmonary hypertension – a diagnostic and therapeutic update
    Hans Stricker (VASA 3/16)

    Raynaud’s phenomenon and digital ischaemia – pharmacologic approach and alternative treatment options
    Birgit Linnemann, Matthias Erbe (VASA 3/16)

    Treatment of acute lower limb ischemia
    Aleksander Lukasiewicz (VASA 3/16)

    Diagnosis of pregnancy-associated venous thromboembolism - position paper of the Working Group in Women’s Health of the Society of Thrombosis and Haemostasis (GTH)
    Birgit Linnemann, Rupert Bauersachs, Hannelore Rott, Susan Halimeh, Rainer Zotz, Andrea Gerhardt, Barbara Boddenberg-Pätzold, Bettina Toth, Ute Scholz (VASA 2/16)

    The association between body mass index and abdominal aortic aneurysm growth: a systematic review
    Hisato Takagi, Takuya Umemoto (VASA 2/16)

    Molecular imaging of atherosclerotic lesions by positron emission tomography - can it meet the expectations? 
    Lindsay Brammen, Sabine Steiner, Robert Berent, Helmut Sinzinger (VASA 2/16)

    Gender differences in patients with carotid stenosis
    Konstanze Stoberock, Eike Sebastian Debus, Atlihan Gülsen, Daum Günther, Axel Larena-Avellaneda, Sandra Eifert, Sabine Wipper (VASA 1/16)

    Inflammatory diseases of the aorta
    Ludwig Caspary (VASA 1/16)

    2015

    Exercise rehabilitation for peripheral artery disease: An exercise physiology perspective with special emphasis on the emerging trend of home-based exercise A. W. Gardner (VASA 6/15)

    Markers of preclinical atherosclerosis and their clinical relevance
    P. Poredos, M. K. Jezovnik (VASA 5/15)

    Raynaud's phanomenon - assesment and differential diagnoses / Raynaud-Phänomen - Diagnostik und Differenzialdiagnose 
    B. Linnemann, M. Erbe (VASA 3/15)

    Hypothenar hammer syndrome / Hypothenar-Hammer-Syndrom
    A. Schröttle, M. Czihal, C. Lottspeich, R. Kuhlencordt, D. Nowak, U. Hoffmann (VASA 3/15)

    Integrative therapy in patients with intermittent claudication / Integrative Therapie bei Patienten mit Claudicatio intermittens
    E. Minar (VASA 2/15)

    Combinded and complex vascular malformations / Kombinierte und komplexe vaskuläre Malformationen
    R. K. Clemens, T. Pfannenmatter, T. O. Meier, A. I. Alomari, B. Amann-Vesti

    Vascular malformations revisited / Gefäßfehlbildungen im Überblick
    Robert K. Clemens, Thomas Pfammatter, Thomas O. Meier, Ahmad I. Alomari und Beatrice R. Amann-Vesti (VASA 1/15)

    Carotid artery disease after head and neck radiotherapy / Strahlenbedingtes Gefäßwandveränderungen der Arteria carotis
    Christoph Thalhammer, Marc Husmann, Christoph Glanzmann, Gabriela Studer und Beatrice R. Amann-Vesti (VASA 1/15)

    2014

    Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications
    L. Pernomian, L. Pernomian, C. Baraldi, A. Restini (VASA 6/14)

    Asymptomatic peripheral artery disease and antiplatelet management
    V. Raparelli, M. Proietti, L. Napoleone, T. Bucci, G. Talerico, F.S. Pignataro und S.Basili (VASA 5/14)

    Lower extremity vasculitis in giant cell arteritis: Important differential diagnosis in patients with lower limb claudication
    M. Sigl, E. Hsu, H. Scheffel, S. Haneder, G. Rümenapf und K. Amendt   (VASA 5/14)

    Thromboangiitis obliterans (Buergers disease)
    P.F. Klein-Weigel und J.G. Richter (VASA 5/14)

    Cancer related venous thromboembolism - prophylaxis and incidence
    T. Gary (VASA 4/14)

    Venous thromboembolism and cancer pathophysiology and incidence 
    H. Striker (VASA 4/14)

    MiRNAs in peripheral artery disease - something gripping this way comes 
    W. Kloss, B. Vogel, E. Blessing (VASA 3/14)

    2013

    State-of-the-art aortic imaging: Part I - fundamentals and perspectives of CT an MRSI
    F. Rengier, P. Geisbüsch, R. Vosshenrich, M. Müller-Eschner, C. Karmonik, P. Schoenhagen, H. von Tengg-Kobligk, S. Partovi (VASA 6/13)

    Restenosis after infrapopliteal angioplasty - clinical importance, study update and further directions
    F. Baumann, N. Diehm (VASA 6/13)

    Livedoid vasculopathy - a thrombic disease
    N. Kerk, T. George (VASA 5/13)

    How to asses and improve cardiopulmonary risk prior to vascular surge?
    A. Mahlmann, R.N. Rodionov, S. Ludwig, J. Neidel, N. Weiss (VASA 5/13)

    Renal denervation - a clinical update and future directions
    K. Mortensen, K. Franzen, M. Reppel, J. Weil (VASA 4/13)

    Vascular accesses for hemodialysis - an update
    C. Thalhammer, T. Pfammatter, S. Segerer (VASA 4/13)

    Catheter-based treatment of ilio-femoral deep vein thrombosis - an update on current evidence
    J. Fahrni, R.P. Engelberger, N. Kucher, T. Willenberg, I. Baumgartner (VASA 3/13)

    Is aspirin still the drug of choice for management of patients with peripheral arterial disease? P. Poredos, M. K. Jezovnik (VASA 2/13)

    May-Thurner Syndrom: Diagnose und Behandlung
    N.F. Brazeau, H. B. Harvey, E. G. Pinto, A. Deipolyi, R. L. Hesketh, R. Oklu (VASA 2/13)

    Influence of glucose metabolism on vascular smooth muscle cell proliferation  
    M. Chiong, P. E. Morales, G. Torres, T. Gutiérrez, L. García, M. Ibacache, L. Michea (VASA 1/13)

    Novel applications of contrast-enhanced ultrasound imaging in vascular medicine D. Staub, S. Partovi, S. Imfeld, H. Uthoff, T. Baldi, M. Aschwanden, K. A. Jaeger (VASA 1/13)

    2012

    Treatment of chronic wounds 
    H. Lawall (VASA 6/12)

    Drug-eluting stents and perioperative risk - more than matters of the heart? 
    C. Lanckohr, G. Torsello, H. H. Scheld, B. Schieffer, G. Theimeier (VASA 6/12)

    Current cencepts of the interventional treatment of proximal supraaortic vessel stenosis 
    U. Ernemann, B. Bender, A. Melms, K. Brechtel, J. Kobba, B. Balletshofer (VASA 5/12)

    Risk factors, management and primary prevention of thrombotic complications related to the use of central venous catheters
    B. Linnemann, E. Lindhoff-Last (VASA 5/12)

    Sclerotherapy in an undetected pregnancy - a catastrophe? 
    S. Reich-Schupke, A. Leiste, R. Moritz, P. Altmeyer, M. Stücker (VASA 4/12)

    Drug-eluting stents and drug-coated balloons in peripheral artery disease 
    R. Buechel, A. Stirnimann, R. Zimmer, H. H. Keo, E. Groechenig (VASA 4/12)

    Popliteal entrapment syndrome and age
    M. Schweiter, R. Hügli, C. Koella, C. Jeanneret (VASA 4/12)

    Novel oral anticoagulants - key messages for the angiologist 
    Sylvia Haas, Michael Spannagl, Sebastian Schellong (VASA 3/12)

    Management of thoratic aortic lesions - the future is endovascular
    R. Weidenhagen, René Bombien, Georgios, Meimarkis, Gerrit Geisler, Thomas Andreas Koeppel (VASA 3/12)

    Health related quality of life in patients with critical limb ischemia - Lebensqualität bei Patienten mit kritischer Extremitätenischämie
    H . Lawall, C. Zemmrich, P. Bramlage, B. Amann (VASA 2/12)

    Drug-eluting stents for treatment of focal infrapopliteal lesions - Medikamenten-beschichtete Stents zur Behandlung fokaler Läsionen der Unterschenkelarterien 
    A. Rastan, E. Noory, T. Zeller (VASA 2/12)

    Revascularization of carotid artery stenosis - a brief update on current evidence H.-C. Koennecke (VASA 1/12)

    Duration if anticoagulation after venous thrombosis 
    S. Eichinger, P.A. Kyrle (VASA 1/12)

    2011

    "Aspirin - resistance?" A few critical considerations on definition, terminology, diagnosis, clinical value, natural course of atherosclerotic disease and therapeutic consequences
    R. Berent, H. Sinzinger (VASA 6/11)

    Vascular anomalies in children
    L. Weibel (VASA 6/11)

    Varicose veins: A critical review of the definition and the therapeutical options - Varikosetherapie: Eine kritische Diskussion  der Definition und der aktuellen Therapiemodalitäten
    C. Jeanneret, K. Karatolios (VASA 5/11)

    Results of open vascular surgical therapy in chronic peripheral arterial disease - Ergebnisse der konventionellen gefäßchirurgischen Therapie bei chronischer peripherer Verschlusserkrankung 
    K. M. Balzer, B. T. Weis-Müller (VASA 5/11)

    Perioperative management and “Fast-Track” therapy in vascular medicine - Perioperatives Management und "Fast-Track" Therapie in der Gefäßmedizin
    E. S. Debus, A. Ivoghli, M. Goepfert, T. Kölbel, A. Larena-Avellaneda (VASA 4/11)

    Therapeutic arteriogenesis in peripheral arterial disease: combining intervention and passive training - Kombination von interventioneller Therapie und passivem Training
    A. Bondke Persson, E.-E. Buschmann, R. Lindhorst, K. Troidl, R. Langhoff, K.-L. Schulte, I. Buschmann (VASA 3/11)

    Multidisciplinary management of vascular access for haemodialysis: from the preparation of the initial access to the treatment of stenosis and thrombosis - Multidisziplinäres Management von Gefäßzugängen zur Hämodialyse
    C. Reinhold, P. Haage, M. Hollenbeck, V. Mickley, J. Ranft (VASA 3/11)

    Management of chronic atherosclerotic mesenteric ischemia - Behandlung der chronischen mesenterialen Ischämie
    T. Zeller, R. Macharzina (VASA 2/11)

    Systemic sclerosis - A systematic overview: Part 1 - Disease characteristics and classification, pathophysiologic concepts, and recommendations for diagnosis and surveillance / Systemische Sklerose - eine systematische Übersicht: Teil 1 - Krankheitscharakteristika und -klassifikation, pathophysiologische Konzepte und Empfehlungen zur Diagnostik und Verlaufskontrolle
    P. Klein-Weigel, C. Opitz, G. Riemekasten (VASA 1/11)

    Systemic sclerosis - A systematic overview: Part 2 - Immunosuppression, treatment of SSc-associated vasculopathy, and treatment of pulmonary arterial hypertension / Systemische Sklerose - eine systematische Übersicht: Teil 2 - Immunsupression, Behandlung der SSc-assoziierten Gefäßerkrankung und der Behandlung der pulmonalen arteriellen Hypertonie
    C. Opitz, P. F. Klein-Weigel, G. Riemekasten (VASA 1/11)

    New aspects of paradoxical embolism / Neue Aspekte der paradoxen Embolie 
    S. Lehmeyer, E. Lindhoff-Last (VASA 1/11)

    2010 (und älter)

    Venous pressure gradients in the lower extremity and the hemodynamic consequences / Venöse Druckunterschiede in der unteren Extremität und ihre hämodynamischen Auswirkungen 
    C. Recek (VASA 4/10)

    Treatment of acute aortic dissection type A (AADA): technical considerations / Behandlungsstrategien der akuten Aortendissektion Typ Stanford A 
    C. Hagl, N. Khaladj, S. Peterss, A. Bonz, M. Pichlmaier, A. Haverich, M. Shrestha (VASA 3/10)

    Fabry disease - Vascular manifestations / Morbus Fabry - Vaskuläre Manifestationen
    D. Karetova, J. Bultas, G. Dostalova, T. Palecek, T. Kovarnik, L. Golan, A. Linhart (VASA 2/10)

    Aortic aneurysms after correction of aortic coarctation: A systemic review / Aortenaneurysmen nach Korrektur einer Coarctatio aortae: Eine systematische Literaturanalyse
    Y. von Kodolitsch, A. M Aydin, A. M Bernhardt, C. Habermann, H. Treede, H. Reichenspurner, T. Meinertz, A. Dodge-Khatami (VASA 1/10)

    Marfan syndrome and the evolving spectrum of heritable thoracic aortic disease: Do we need genetics for clinical decisions? / Marfan-Syndrom und das Spektrum angeborener thorakaler Aortenerkrankungen: Brauchen wir die Genetik, um klinische Entscheidungen zu treffen? 
    Y. von Kodolitsch, M. Rybczynski, A. Bernhardt, T. S Mir, H. Treede, A. Dodge-Khatami, P. N Robinson, S. Sheikhzadeh, H. Reichenspurner, T. Meinertz (VASA 1/10)

    Cannabis-associated arteritis / Cannabis-assoziierte Arteritis 
    F. Grotenhermen (VASA 1/10)

    Carotid artery stenting: A systematic review of randomized clinical trials / Carotid artery stenting (CAS): eine systematische Analyse randomisierter klinischer Studien
    R. Knur (VASA 4/09)

    New developments in tissue engineering of vascular prosthetic grafts / Tissue engineering: neue Entwicklungen zur Schaffung einer idealen Kunststoffprothese
    T. Aper, A. Haverich, O. Teebken (VASA 2/09)

    New techniques for endovascular treatment of peripheral artery disease with focus on chronic critical limb ischemia 
    T. Zeller, S. Sixt, A. Rastan (VASA 1 /09)

    New anticoagulants - towards the development of an "ideal" anticoagulant 
    S. Haas (VASA 1 /09)

    Nephrogenic systemic fibrosis
    R. Vosshenrich, P. Reimer (VASA 1 /09)

    Traveller's thrombosis: International consensus statement / Die Reisethrombose: Stellungnahme der Internationalen Konsensuskonferenz W. Schobersberger, W. D. Toff, B. Eklöf, G. Fraedrich, H. C. Gunga, S. Haas, H. Landgraf, F. Lapostolle, H. Partsch, F. Perschler, J. Schapka, B. Schobersberger, J. H. Scurr, H. Watzke (VASA 4/08)

    Studies on travel-related thrombosis / Studienlage zur Reisethrombose
    P. Haas, H. Landgraf (VASA 4/08)

    High-energy phosphate metabolism in the exercising muscle of patients with peripheral arterial disease / Stoffwechsel der energiereichen Phosphate unter Muskelbelastung bei Patienten mit peripherer arterieller Verschlusskrankheit 
    M. Schocke, R. Esterhammer, A. Greiner (VASA 4/08)

    Assessment of generic and disease-specific health-related quality of life instruments in peripheral arterial disease / Die Erfassung der allgemeinen und gesundheitsbezogenen Lebensqualität bei Patienten mit peripherer arterieller Verschlusskrankheit - eine Übersicht 
    E. Knipfer, C. Reeps, C. Dolezal, A. Zimmermann, J. Pelisek, J. Behrens, H.-H. Eckstein (VASA 2/08)

    Therapeutic angiogenesis for peripheral artery disease: Stem cell therapy / Therapeutische Angiogenese zur Behandlung der peripheren arteriellen Verschlusskrankheit: Stammzelltherapie
    N. Lachmann, S. Nikol (VASA 4/07)

    Therapeutic angiogenesis for peripheral artery disease: Cytokine therapy / Therapeutische Angiogenese zur Behandlung der peripheren arteriellen Verschlusskrankheit: Zytokintherapie
    M. T. Kuhlmann, R. Klocke, S. Nikol (VASA 4/07)

    Is atherosclerosis a mitochondrial disorder? / Ist die Atherosklerose eine mitochondriale Erkrankung?
    J. Finsterer (VASA 4/07)

    Therapeutic angiogenesis for peripheral artery disease - Gene therapy / Therapeutische Angiogenese zur Behandlung der arteriellen Verschlusskrankheit – Gentherapie 
    S. Nikol (VASA 3/07)

    Login

    Geben Sie Ihre E-Mail Adresse und Ihr Passwort ein, um sich im Mitgliederbereich anzumelden.